Home > M&A deals 2021 > Sorrento Therapeutics, Inc. acquires Acea Therapeutics, Inc.
Add-on Acquistion · Life Science · April 2021

Sorrento Therapeutics, Inc. acquires Acea Therapeutics, Inc.

On April 5, 2021, Sorrento Therapeutics, Inc. acquired Acea Therapeutics, Inc., a life science company in California, United States.

Deal at a glance

AnnouncedApril 5, 2021 TypeAdd-on Acquistion TargetAcea Therapeutics, Inc. Buyer Sorrento Therapeutics, Inc. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Acea Therapeutics, Inc.
California, United States
Life Sciencesector
2017founded
Activestatus
View the company profile →

Buyer

Sorrento Therapeutics, Inc.
Company · 9 deals on record
  • 5th transaction in life science
  • 6th transaction in United States
9deals, all time
6in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

ZhengZhou Fortune Bioscience Co., Ltd.Same lead buyer · Feb 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Acea Therapeutics, Inc.?Sorrento Therapeutics, Inc. acquired Acea Therapeutics, Inc. on April 5, 2021.

What type of deal was it?It was a add-on acquistion in the life science sector in 2021.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).